Novartis and Amgen have announced that Aimovig® has been approved by the US FDA for the preventive treatment of migraine in adults.
In this research article from Pain Management, researchers investigate the effects of pregabalin, gabapentin and gastroretentive gabapentin on simulated driving performance.
Editor’s summary considering the effectiveness and tolerability of octagam in patients with chronic inflammatory demyelinating polyneuropathy.
In these interviews, we speak to four early career researchers whose respective research findings were highlighted by the Society as ones to watch in the coming years.
Key research from the conference highlights opioid addiction research.
Listen to our latest NCTalks podcast with leading neurosurgeon, Ali Rezai, to hear more about his work, how neuromodulation can be harnessed to treat ‘alternative’ conditions, and where he hopes the field will progress in the next decade.
Participants receiving the antibody treatment were also able to take less additional migraine medication compared with those in the placebo group.
Research presented at the Congress of the European Academy of Neurology 2017 confirms that cannabinoids are as suitable for preventing migraine attacks as other pharmaceutical treatments.
This review explores the limitations of the present technology and current challenges of SCS before reviewing some of the most important recent advances.